Investor profile for Scion Life Sciences: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Scion Life Sciences stages, portfolio and investment profile

Scion Life Sciences is a US biotechnology venture-creation and investment firm building and financing drug-development companies. The firm founded Marrow Therapeutics and co-led its $53M Series A; this manager profile is not a new fund closing.

Keep track of Scion Life Sciences

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$100K–$1M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: November 18, 2026 View methodology

Investment stages

Leads: Not recorded

Participates: Not recorded

Sector focus

Not recorded

Geography

United States

Founded Not recorded

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

1

Linked startup profiles

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Rounds they invest

Last verified: 2026-11-18T00:00:00.000Z. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

Portfolio companies we track

Startups in our directory that list Scion Life Sciences as an investor (1 total).

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.